News
Novartis invests $250m in malaria elimination commitment
Novartis has endorsed the ‘Kigali Declaration’ on neglected tropical diseases (NTDs) by announcing a five-year financial commitment of $250m.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Novartis has endorsed the ‘Kigali Declaration’ on neglected tropical diseases (NTDs) by announcing a five-year financial commitment of $250m.